Tech Firm AEGROS Inks $400M Deal for HaemaFrac Plants

CIOTechOutlook Team | Monday, 07 August 2023, 03:39 IST

  •  No Image
AEGROS announced a breakthrough deal to build a fully funded, one million liter HaemaFrac plasma fractionation facility in Singapore for US$400 million in order to provide the Asian market with locally produced plasma. The Royal Group Plasma Fractionation joint venture was established by the Royal Group of Companies, Fresh Start (Australia), and Aegros.
 
According to estimates, Asia discards more than 2 million liters of plasma annually that cannot be handled by the current fractionators. With the HaemaFrac, this underutilized national resource can be converted into beneficial Plasma Derived Medical Products (PDMP), saving lives and lowering the cost of these life-saving medications. The organization will also construct additional plasma collection facilities and work with local blood collection/transfusion facilities to increase their standards to par with worldwide best practices in order to guarantee the long-term sustainability/supply of these PDMP.
 
in an effort to increase the supply of PDMP that is already widely available in the bigger Asian markets, such as those in Singapore and Cambodia.
 
Another advantage of this joint venture's PDMP production is the use of local plasma. Local plasma is frequently contaminated with antibodies to local diseases. In other words, a better or more useful product will be produced for the community if local plasma is used. Additionally, the project will enable Southeast Asian countries become national self-sufficient in medications produced from plasma, enabling them to meet World Health Assembly requirements.
 
Co-Founder Professor Hari Nair said today of the deal, "Our technology and IP will not just change the way Australia undertakes plasma fractionation but how plasma is fractionated globally. This deal represents Aegros' first overseas expansion and in another world first, will use plasma currently collected in Asia which cannot be processed by the existing fractionators."